We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.18%
AUM
$9B
AUM Growth
+$1.19B
Cap. Flow
+$454M
Cap. Flow %
5.04%
Top 10 Hldgs %
32.41%
Holding
435
New
32
Increased
155
Reduced
116
Closed
11

Top Buys

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$77.8M
2
DXCM icon
DexCom
DXCM
+$76.1M
3
ISRG icon
Intuitive Surgical
ISRG
+$69.9M
4
SBNY
Signature Bank
SBNY
+$62.3M
5
MS icon
Morgan Stanley
MS
+$22.9M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$79.2M
2
RNG icon
RingCentral
RNG
+$71M
3
NFLX icon
Netflix
NFLX
+$65M
4
JKHY icon
Jack Henry & Associates
JKHY
+$58.7M
5
PTC icon
PTC
PTC
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 22.46%
2 Financials 20.13%
3 Consumer Staples 11.43%
4 Healthcare 11.1%
5 Consumer Discretionary 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FXI icon
326
iShares China Large-Cap ETF
FXI
$4.29B
$427K ﹤0.01%
9,215
-1,110
-11% -$51.2K
TGI
327
DELISTED
Triumph Group
TGI
$415K ﹤0.01%
20,000
– –
SRE icon
328
Sempra
SRE
$61.1B
$411K ﹤0.01%
6,200
– –
DOW icon
329
Dow Inc
DOW
$22.3B
$401K ﹤0.01%
6,344
– –
TRHC
330
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$400K ﹤0.01%
7,990
+100
+1% +$4.47K
ZS icon
331
Zscaler
ZS
$22.6B
$395K ﹤0.01%
1,827
– –
SRNE
332
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$395K ﹤0.01%
40,784
-1,700
-4% -$13.5K
PPTA
333
Perpetua Resources
PPTA
$2.23B
$390K ﹤0.01%
53,200
– –
NIO icon
334
NIO
NIO
$11.6B
$388K ﹤0.01%
7,284
-975
-12% -$39K
BLFS icon
335
BioLife Solutions
BLFS
$1.5B
$386K ﹤0.01%
8,668
-350
-4% -$12.3K
ZM icon
336
Zoom
ZM
$24.7B
$380K ﹤0.01%
981
-221
-18% -$73.6K
CHTR icon
337
Charter Communications
CHTR
$15.6B
$373K ﹤0.01%
517
– –
UNH icon
338
UnitedHealth
UNH
$385B
$373K ﹤0.01%
931
-60
-6% -$23.9K
WAB icon
339
Wabtec
WAB
$50.3B
$372K ﹤0.01%
4,525
-885
-16% -$71.8K
HCM icon
340
HUTCHMED
HCM
$1.88B
$371K ﹤0.01%
9,450
– –
XPEV icon
341
XPeng
XPEV
$12.2B
$369K ﹤0.01%
+8,315
New +$283K
QVCGA
342
DELISTED
QVC Group Inc Series A
QVCGA
$367K ﹤0.01%
560
+300
+115% +$193K
SILK
343
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$357K ﹤0.01%
7,450
– –
RDS.A
344
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$357K ﹤0.01%
8,845
– –
MKL icon
345
Markel Group
MKL
$24.5B
$354K ﹤0.01%
298
– –
VBR icon
346
Vanguard Small-Cap Value ETF
VBR
$36.8B
$347K ﹤0.01%
2,000
– –
AMT icon
347
American Tower
AMT
$76.7B
$344K ﹤0.01%
1,272
-250
-16% -$63.7K
ARES icon
348
Ares Management
ARES
$27.4B
$337K ﹤0.01%
5,300
– –
EXEL icon
349
Exelixis
EXEL
$14B
$337K ﹤0.01%
18,500
– –
VTRS icon
350
Viatris
VTRS
$20.1B
$333K ﹤0.01%
23,317
-5,482
-19% -$79.3K
12 13
14
15 16

Similar funds

Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Rathbones Group's Q2 2021 Portfolio in Review

As of Q2 2021, Rathbones Group held 435 positions worth $9B, up 15% from $7.81B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rathbones Group deployed $454M of net new capital in Q2 2021, opening 32 new positions and adding to 155 existing holdings. Its largest new stake was Monster Beverage: 1,658,800 shares worth $75.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Nike, an estimated $79.2M trimmed.

  • Rathbones Group's largest Q2 2021 buy was Monster Beverage: 1,658,800 shares worth $75.8M.
  • Rathbones Group added most to DexCom in Q2 2021, an estimated $76.1M increase.
  • Rathbones Group's biggest Q2 2021 reduction was Nike, cutting an estimated $79.2M.
  • Rathbones Group fully exited RingCentral in Q2 2021, selling an estimated $71M.
  • Rathbones Group's ten largest holdings make up 32% of its $9B portfolio in Q2 2021.
  • Rathbones Group opened 32 new positions and closed 11 in Q2 2021.
  • Rathbones Group's portfolio value rose 15% quarter-over-quarter to $9B.

Based on Rathbones Group's 13F filing for Q2 2021, filed 30 Jul 2021.